Advertisement
Advertisement

ASTH

ASTH logo

Astrana Health Inc. Common Stock

43.03
USD
Sponsored
+0.76
+1.80%
Jun 25, 13:11 UTC -4
Open

ASTH Earnings Reports

Positive Surprise Ratio

ASTH beat 19 of 32 last estimates.

59%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.01B
/
$0.33
Implied change from Q1 26 (Revenue/ EPS)
+4.18%
/
+17.86%
Implied change from Q2 25 (Revenue/ EPS)
+53.55%
/
+73.68%

Astrana Health Inc. Common Stock earnings per share and revenue

On May 07, 2026, ASTH reported earnings of 0.28 USD per share (EPS) for Q1 26, missing the estimate of 0.30 USD, resulting in a -4.89% surprise. Revenue reached 965.10 million, compared to an expected 968.19 million, with a -0.32% difference. The market reacted with a +8.92% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of 0.33 USD, with revenue projected to reach 1.01 billion USD, implying an increase of 17.86% EPS, and increase of 4.18% in Revenue from the last quarter.
FAQ
For Q1 2026, Astrana Health Inc. Common Stock reported EPS of $0.28, missing estimates by -4.89%, and revenue of $965.10M, -0.32% below expectations.
The stock price moved up 8.92%, changed from $36.08 before the earnings release to $39.30 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 9 analysts, Astrana Health Inc. Common Stock is expected to report EPS of $0.33 and revenue of $1.01B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement